Literature DB >> 21221113

Motor neuron disease: urgently needed-biomarkers for amyotrophic lateral sclerosis.

Albert C Ludolph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21221113     DOI： 10.1038/nrneurol.2010.196

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

2.  Onset and progression in inherited ALS determined by motor neurons and microglia.

Authors:  Séverine Boillée; Koji Yamanaka; Christian S Lobsiger; Neal G Copeland; Nancy A Jenkins; George Kassiotis; George Kollias; Don W Cleveland
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Axonal damage markers in cerebrospinal fluid are increased in ALS.

Authors:  J Brettschneider; A Petzold; S D Süssmuth; A C Ludolph; H Tumani
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

5.  Plasma biomarkers associated with ALS and their relationship to iron homeostasis.

Authors:  Ryan M Mitchell; Zachary Simmons; John L Beard; Helen E Stephens; James R Connor
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

6.  Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.

Authors:  Heiko Braak; Albert Ludolph; Dietmar R Thal; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2010-04-09       Impact factor: 17.088

7.  CSF glial markers correlate with survival in amyotrophic lateral sclerosis.

Authors:  S D Süssmuth; A D Sperfeld; A Hinz; J Brettschneider; S Endruhn; A C Ludolph; H Tumani
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

Review 8.  Biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Matthew C Kiernan; P Nigel Leigh; Kevin Talbot
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

9.  TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Petra Steinacker; Corinna Hendrich; Anne D Sperfeld; Sarah Jesse; Christine A F von Arnim; Stefan Lehnert; Alice Pabst; Ingo Uttner; Hayrettin Tumani; Virginia M-Y Lee; John Q Trojanowski; Hans A Kretzschmar; Albert Ludolph; Manuela Neumann; Markus Otto
Journal:  Arch Neurol       Date:  2008-11
  9 in total
  4 in total

1.  Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.

Authors:  Franck Patin; Thomas Baranek; Patrick Vourc'h; Lydie Nadal-Desbarats; Jean-François Goossens; Sylviane Marouillat; Anne-Frédérique Dessein; Amandine Descat; Blandine Madji Hounoum; Clément Bruno; Hervé Watier; Mustafa Si-Tahar; Samuel Leman; Jean-Claude Lecron; Christian R Andres; Philippe Corcia; Hélène Blasco
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

2.  Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia.

Authors:  Gabriele Nagel; Hatice Unal; Angela Rosenbohm; Albert C Ludolph; Dietrich Rothenbacher
Journal:  BMC Neurol       Date:  2013-02-17       Impact factor: 2.474

3.  LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

Authors:  John S Tzartos; Paraskevi Zisimopoulou; Michael Rentzos; Nikos Karandreas; Vasiliki Zouvelou; Panagiota Evangelakou; Anastasios Tsonis; Thomas Thomaidis; Giuseppe Lauria; Francesca Andreetta; Renato Mantegazza; Socrates J Tzartos
Journal:  Ann Clin Transl Neurol       Date:  2013-12-30       Impact factor: 4.511

4.  Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.

Authors:  Yu Zhu; Mi Yang; Fangjun Li; Menghua Li; Zhenzhen Xu; Fang Yang; Yue Liu; Wenzhi Chen; Yougen Zhang; Renshi Xu
Journal:  Int J Biol Sci       Date:  2018-06-03       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.